nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—CYP1A1—Cholecalciferol—osteoporosis	0.124	0.262	CbGbCtD
Dexmedetomidine—CYP1A2—Estropipate—osteoporosis	0.108	0.228	CbGbCtD
Dexmedetomidine—CYP1A1—Estradiol—osteoporosis	0.1	0.211	CbGbCtD
Dexmedetomidine—CYP1A2—Conjugated Estrogens—osteoporosis	0.051	0.108	CbGbCtD
Dexmedetomidine—CYP2D6—Cholecalciferol—osteoporosis	0.0457	0.0966	CbGbCtD
Dexmedetomidine—CYP1A2—Estradiol—osteoporosis	0.0447	0.0945	CbGbCtD
Dexmedetomidine—Feeling abnormal—Etidronic acid—osteoporosis	0.000678	0.00158	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Zoledronate—osteoporosis	0.000677	0.00158	CcSEcCtD
Dexmedetomidine—Alanine aminotransferase increased—Estradiol—osteoporosis	0.000675	0.00157	CcSEcCtD
Dexmedetomidine—Chills—Pamidronate—osteoporosis	0.000675	0.00157	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Raloxifene—osteoporosis	0.000675	0.00157	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.000673	0.00157	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Raloxifene—osteoporosis	0.000666	0.00155	CcSEcCtD
Dexmedetomidine—Abdominal distension—Estradiol—osteoporosis	0.000666	0.00155	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Ibandronate—osteoporosis	0.00066	0.00154	CcSEcCtD
Dexmedetomidine—Nausea—Ergocalciferol—osteoporosis	0.000657	0.00153	CcSEcCtD
Dexmedetomidine—Malnutrition—Pamidronate—osteoporosis	0.000655	0.00153	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.000652	0.00152	CcSEcCtD
Dexmedetomidine—Bronchospasm—Estradiol—osteoporosis	0.000651	0.00152	CcSEcCtD
Dexmedetomidine—Abdominal pain—Etidronic acid—osteoporosis	0.00065	0.00151	CcSEcCtD
Dexmedetomidine—Sweating increased—Estradiol—osteoporosis	0.000645	0.0015	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Zoledronate—osteoporosis	0.000638	0.00149	CcSEcCtD
Dexmedetomidine—Visual impairment—Conjugated Estrogens—osteoporosis	0.000638	0.00149	CcSEcCtD
Dexmedetomidine—Anaemia—Risedronate—osteoporosis	0.000637	0.00148	CcSEcCtD
Dexmedetomidine—Somnolence—Estropipate—osteoporosis	0.000633	0.00147	CcSEcCtD
Dexmedetomidine—Angiopathy—Zoledronate—osteoporosis	0.000624	0.00145	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Zoledronate—osteoporosis	0.000619	0.00144	CcSEcCtD
Dexmedetomidine—Chills—Zoledronate—osteoporosis	0.000617	0.00144	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000614	0.00143	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000614	0.00143	CcSEcCtD
Dexmedetomidine—Arrhythmia—Zoledronate—osteoporosis	0.000614	0.00143	CcSEcCtD
Dexmedetomidine—Pain—Estropipate—osteoporosis	0.000609	0.00142	CcSEcCtD
Dexmedetomidine—Constipation—Estropipate—osteoporosis	0.000609	0.00142	CcSEcCtD
Dexmedetomidine—Anaemia—Pamidronate—osteoporosis	0.000605	0.00141	CcSEcCtD
Dexmedetomidine—Mental disorder—Zoledronate—osteoporosis	0.000602	0.0014	CcSEcCtD
Dexmedetomidine—Agitation—Pamidronate—osteoporosis	0.000602	0.0014	CcSEcCtD
Dexmedetomidine—Angiopathy—Conjugated Estrogens—osteoporosis	0.0006	0.0014	CcSEcCtD
Dexmedetomidine—Anxiety—Ethinyl Estradiol—osteoporosis	0.0006	0.0014	CcSEcCtD
Dexmedetomidine—Pain—Alendronate—osteoporosis	0.000599	0.0014	CcSEcCtD
Dexmedetomidine—Constipation—Alendronate—osteoporosis	0.000599	0.0014	CcSEcCtD
Dexmedetomidine—Malnutrition—Zoledronate—osteoporosis	0.000598	0.00139	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Estradiol—osteoporosis	0.000597	0.00139	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000596	0.00139	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000595	0.00139	CcSEcCtD
Dexmedetomidine—Hypertension—Risedronate—osteoporosis	0.000595	0.00139	CcSEcCtD
Dexmedetomidine—Somnolence—Calcitriol—osteoporosis	0.000594	0.00138	CcSEcCtD
Dexmedetomidine—Pneumonia—Estradiol—osteoporosis	0.000594	0.00138	CcSEcCtD
Dexmedetomidine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000591	0.00138	CcSEcCtD
Dexmedetomidine—Pain—Raloxifene—osteoporosis	0.000589	0.00137	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000589	0.00137	CcSEcCtD
Dexmedetomidine—Anxiety—Risedronate—osteoporosis	0.000585	0.00136	CcSEcCtD
Dexmedetomidine—Pain—Ibandronate—osteoporosis	0.000584	0.00136	CcSEcCtD
Dexmedetomidine—Constipation—Ibandronate—osteoporosis	0.000584	0.00136	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Estropipate—osteoporosis	0.000582	0.00136	CcSEcCtD
Dexmedetomidine—Acute coronary syndrome—Estradiol—osteoporosis	0.000582	0.00135	CcSEcCtD
Dexmedetomidine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00058	0.00135	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Estradiol—osteoporosis	0.000578	0.00135	CcSEcCtD
Dexmedetomidine—Myocardial infarction—Estradiol—osteoporosis	0.000578	0.00135	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Alendronate—osteoporosis	0.000578	0.00135	CcSEcCtD
Dexmedetomidine—Malnutrition—Conjugated Estrogens—osteoporosis	0.000576	0.00134	CcSEcCtD
Dexmedetomidine—Dry mouth—Risedronate—osteoporosis	0.000574	0.00134	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Estradiol—osteoporosis	0.000574	0.00134	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Alendronate—osteoporosis	0.000573	0.00133	CcSEcCtD
Dexmedetomidine—Infection—Ethinyl Estradiol—osteoporosis	0.000573	0.00133	CcSEcCtD
Dexmedetomidine—Pain—Calcitriol—osteoporosis	0.000571	0.00133	CcSEcCtD
Dexmedetomidine—Constipation—Calcitriol—osteoporosis	0.000571	0.00133	CcSEcCtD
Dexmedetomidine—Convulsion—Pamidronate—osteoporosis	0.000568	0.00132	CcSEcCtD
Dexmedetomidine—Hypertension—Pamidronate—osteoporosis	0.000566	0.00132	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000564	0.00131	CcSEcCtD
Dexmedetomidine—Diarrhoea—Etidronic acid—osteoporosis	0.000563	0.00131	CcSEcCtD
Dexmedetomidine—Abdominal pain—Estropipate—osteoporosis	0.000563	0.00131	CcSEcCtD
Dexmedetomidine—Body temperature increased—Estropipate—osteoporosis	0.000563	0.00131	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Ibandronate—osteoporosis	0.000562	0.00131	CcSEcCtD
Dexmedetomidine—Infection—Risedronate—osteoporosis	0.000559	0.0013	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000558	0.0013	CcSEcCtD
Dexmedetomidine—Anxiety—Pamidronate—osteoporosis	0.000556	0.00129	CcSEcCtD
Dexmedetomidine—Body temperature increased—Alendronate—osteoporosis	0.000554	0.00129	CcSEcCtD
Dexmedetomidine—Abdominal pain—Alendronate—osteoporosis	0.000554	0.00129	CcSEcCtD
Dexmedetomidine—Anaemia—Zoledronate—osteoporosis	0.000553	0.00129	CcSEcCtD
Dexmedetomidine—Agitation—Zoledronate—osteoporosis	0.00055	0.00128	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000546	0.00127	CcSEcCtD
Dexmedetomidine—Abdominal pain—Raloxifene—osteoporosis	0.000545	0.00127	CcSEcCtD
Dexmedetomidine—Body temperature increased—Raloxifene—osteoporosis	0.000545	0.00127	CcSEcCtD
Dexmedetomidine—Abdominal pain—Ibandronate—osteoporosis	0.000539	0.00126	CcSEcCtD
Dexmedetomidine—Body temperature increased—Ibandronate—osteoporosis	0.000539	0.00126	CcSEcCtD
Dexmedetomidine—Confusional state—Pamidronate—osteoporosis	0.000539	0.00126	CcSEcCtD
Dexmedetomidine—Haemoglobin—Estradiol—osteoporosis	0.000532	0.00124	CcSEcCtD
Dexmedetomidine—Infection—Pamidronate—osteoporosis	0.000531	0.00124	CcSEcCtD
Dexmedetomidine—Haemorrhage—Estradiol—osteoporosis	0.00053	0.00123	CcSEcCtD
Dexmedetomidine—Body temperature increased—Calcitriol—osteoporosis	0.000528	0.00123	CcSEcCtD
Dexmedetomidine—Abdominal pain—Calcitriol—osteoporosis	0.000528	0.00123	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Pamidronate—osteoporosis	0.000523	0.00122	CcSEcCtD
Dexmedetomidine—Vomiting—Etidronic acid—osteoporosis	0.000523	0.00122	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Estradiol—osteoporosis	0.000522	0.00122	CcSEcCtD
Dexmedetomidine—Tachycardia—Pamidronate—osteoporosis	0.000522	0.00122	CcSEcCtD
Dexmedetomidine—Rash—Etidronic acid—osteoporosis	0.000519	0.00121	CcSEcCtD
Dexmedetomidine—Convulsion—Zoledronate—osteoporosis	0.000518	0.00121	CcSEcCtD
Dexmedetomidine—Dermatitis—Etidronic acid—osteoporosis	0.000518	0.00121	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Pamidronate—osteoporosis	0.000517	0.0012	CcSEcCtD
Dexmedetomidine—Hypertension—Zoledronate—osteoporosis	0.000517	0.0012	CcSEcCtD
Dexmedetomidine—Headache—Etidronic acid—osteoporosis	0.000515	0.0012	CcSEcCtD
Dexmedetomidine—Visual impairment—Estradiol—osteoporosis	0.00051	0.00119	CcSEcCtD
Dexmedetomidine—Anxiety—Zoledronate—osteoporosis	0.000508	0.00118	CcSEcCtD
Dexmedetomidine—Dyspnoea—Risedronate—osteoporosis	0.000501	0.00117	CcSEcCtD
Dexmedetomidine—Hypotension—Pamidronate—osteoporosis	0.0005	0.00116	CcSEcCtD
Dexmedetomidine—Convulsion—Conjugated Estrogens—osteoporosis	0.000499	0.00116	CcSEcCtD
Dexmedetomidine—Dry mouth—Zoledronate—osteoporosis	0.000498	0.00116	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000498	0.00116	CcSEcCtD
Dexmedetomidine—Constipation—Ethinyl Estradiol—osteoporosis	0.000493	0.00115	CcSEcCtD
Dexmedetomidine—Confusional state—Zoledronate—osteoporosis	0.000492	0.00115	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Estradiol—osteoporosis	0.000492	0.00114	CcSEcCtD
Dexmedetomidine—Anxiety—Conjugated Estrogens—osteoporosis	0.000489	0.00114	CcSEcCtD
Dexmedetomidine—Nausea—Etidronic acid—osteoporosis	0.000489	0.00114	CcSEcCtD
Dexmedetomidine—Diarrhoea—Estropipate—osteoporosis	0.000487	0.00113	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000486	0.00113	CcSEcCtD
Dexmedetomidine—Infection—Zoledronate—osteoporosis	0.000485	0.00113	CcSEcCtD
Dexmedetomidine—Pain—Risedronate—osteoporosis	0.000481	0.00112	CcSEcCtD
Dexmedetomidine—Constipation—Risedronate—osteoporosis	0.000481	0.00112	CcSEcCtD
Dexmedetomidine—Angiopathy—Estradiol—osteoporosis	0.000481	0.00112	CcSEcCtD
Dexmedetomidine—Diarrhoea—Alendronate—osteoporosis	0.00048	0.00112	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Zoledronate—osteoporosis	0.000478	0.00111	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Estradiol—osteoporosis	0.000477	0.00111	CcSEcCtD
Dexmedetomidine—Dyspnoea—Pamidronate—osteoporosis	0.000477	0.00111	CcSEcCtD
Dexmedetomidine—Tachycardia—Zoledronate—osteoporosis	0.000477	0.00111	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000475	0.00111	CcSEcCtD
Dexmedetomidine—Chills—Estradiol—osteoporosis	0.000475	0.00111	CcSEcCtD
Dexmedetomidine—Somnolence—Pamidronate—osteoporosis	0.000475	0.00111	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Zoledronate—osteoporosis	0.000472	0.0011	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000472	0.0011	CcSEcCtD
Dexmedetomidine—Diarrhoea—Raloxifene—osteoporosis	0.000472	0.0011	CcSEcCtD
Dexmedetomidine—Dizziness—Estropipate—osteoporosis	0.000471	0.0011	CcSEcCtD
Dexmedetomidine—Infection—Conjugated Estrogens—osteoporosis	0.000467	0.00109	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ibandronate—osteoporosis	0.000467	0.00109	CcSEcCtD
Dexmedetomidine—Mental disorder—Estradiol—osteoporosis	0.000464	0.00108	CcSEcCtD
Dexmedetomidine—Dizziness—Alendronate—osteoporosis	0.000464	0.00108	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000462	0.00107	CcSEcCtD
Dexmedetomidine—Malnutrition—Estradiol—osteoporosis	0.000461	0.00107	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Risedronate—osteoporosis	0.00046	0.00107	CcSEcCtD
Dexmedetomidine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000459	0.00107	CcSEcCtD
Dexmedetomidine—Pain—Pamidronate—osteoporosis	0.000457	0.00106	CcSEcCtD
Dexmedetomidine—Constipation—Pamidronate—osteoporosis	0.000457	0.00106	CcSEcCtD
Dexmedetomidine—Diarrhoea—Calcitriol—osteoporosis	0.000457	0.00106	CcSEcCtD
Dexmedetomidine—Hypotension—Zoledronate—osteoporosis	0.000456	0.00106	CcSEcCtD
Dexmedetomidine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000456	0.00106	CcSEcCtD
Dexmedetomidine—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000456	0.00106	CcSEcCtD
Dexmedetomidine—Dizziness—Raloxifene—osteoporosis	0.000456	0.00106	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000455	0.00106	CcSEcCtD
Dexmedetomidine—Vomiting—Estropipate—osteoporosis	0.000452	0.00105	CcSEcCtD
Dexmedetomidine—Dizziness—Ibandronate—osteoporosis	0.000451	0.00105	CcSEcCtD
Dexmedetomidine—Rash—Estropipate—osteoporosis	0.000449	0.00104	CcSEcCtD
Dexmedetomidine—Dermatitis—Estropipate—osteoporosis	0.000448	0.00104	CcSEcCtD
Dexmedetomidine—Headache—Estropipate—osteoporosis	0.000446	0.00104	CcSEcCtD
Dexmedetomidine—Vomiting—Alendronate—osteoporosis	0.000446	0.00104	CcSEcCtD
Dexmedetomidine—Abdominal pain—Risedronate—osteoporosis	0.000445	0.00104	CcSEcCtD
Dexmedetomidine—Body temperature increased—Risedronate—osteoporosis	0.000445	0.00104	CcSEcCtD
Dexmedetomidine—Rash—Alendronate—osteoporosis	0.000442	0.00103	CcSEcCtD
Dexmedetomidine—Dermatitis—Alendronate—osteoporosis	0.000442	0.00103	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Pamidronate—osteoporosis	0.000441	0.00103	CcSEcCtD
Dexmedetomidine—Hypotension—Conjugated Estrogens—osteoporosis	0.000439	0.00102	CcSEcCtD
Dexmedetomidine—Headache—Alendronate—osteoporosis	0.000439	0.00102	CcSEcCtD
Dexmedetomidine—Vomiting—Raloxifene—osteoporosis	0.000438	0.00102	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000437	0.00102	CcSEcCtD
Dexmedetomidine—Dyspnoea—Zoledronate—osteoporosis	0.000435	0.00101	CcSEcCtD
Dexmedetomidine—Rash—Raloxifene—osteoporosis	0.000435	0.00101	CcSEcCtD
Dexmedetomidine—Dermatitis—Raloxifene—osteoporosis	0.000434	0.00101	CcSEcCtD
Dexmedetomidine—Somnolence—Zoledronate—osteoporosis	0.000434	0.00101	CcSEcCtD
Dexmedetomidine—Vomiting—Ibandronate—osteoporosis	0.000434	0.00101	CcSEcCtD
Dexmedetomidine—Headache—Raloxifene—osteoporosis	0.000432	0.00101	CcSEcCtD
Dexmedetomidine—Rash—Ibandronate—osteoporosis	0.00043	0.001	CcSEcCtD
Dexmedetomidine—Dermatitis—Ibandronate—osteoporosis	0.00043	0.001	CcSEcCtD
Dexmedetomidine—Headache—Ibandronate—osteoporosis	0.000428	0.000996	CcSEcCtD
Dexmedetomidine—Vomiting—Calcitriol—osteoporosis	0.000425	0.000989	CcSEcCtD
Dexmedetomidine—Agitation—Estradiol—osteoporosis	0.000424	0.000987	CcSEcCtD
Dexmedetomidine—Nausea—Estropipate—osteoporosis	0.000423	0.000984	CcSEcCtD
Dexmedetomidine—Abdominal pain—Pamidronate—osteoporosis	0.000423	0.000984	CcSEcCtD
Dexmedetomidine—Body temperature increased—Pamidronate—osteoporosis	0.000423	0.000984	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000422	0.000982	CcSEcCtD
Dexmedetomidine—Rash—Calcitriol—osteoporosis	0.000421	0.000981	CcSEcCtD
Dexmedetomidine—Dermatitis—Calcitriol—osteoporosis	0.000421	0.00098	CcSEcCtD
Dexmedetomidine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000419	0.000976	CcSEcCtD
Dexmedetomidine—Headache—Calcitriol—osteoporosis	0.000419	0.000975	CcSEcCtD
Dexmedetomidine—Somnolence—Conjugated Estrogens—osteoporosis	0.000418	0.000974	CcSEcCtD
Dexmedetomidine—Constipation—Zoledronate—osteoporosis	0.000418	0.000973	CcSEcCtD
Dexmedetomidine—Pain—Zoledronate—osteoporosis	0.000418	0.000973	CcSEcCtD
Dexmedetomidine—Nausea—Alendronate—osteoporosis	0.000416	0.00097	CcSEcCtD
Dexmedetomidine—Nausea—Raloxifene—osteoporosis	0.000409	0.000954	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000406	0.000945	CcSEcCtD
Dexmedetomidine—Nausea—Ibandronate—osteoporosis	0.000405	0.000944	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Zoledronate—osteoporosis	0.000402	0.000937	CcSEcCtD
Dexmedetomidine—Pain—Conjugated Estrogens—osteoporosis	0.000402	0.000936	CcSEcCtD
Dexmedetomidine—Constipation—Conjugated Estrogens—osteoporosis	0.000402	0.000936	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000399	0.00093	CcSEcCtD
Dexmedetomidine—Hypertension—Estradiol—osteoporosis	0.000398	0.000927	CcSEcCtD
Dexmedetomidine—Nausea—Calcitriol—osteoporosis	0.000397	0.000924	CcSEcCtD
Dexmedetomidine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000395	0.000919	CcSEcCtD
Dexmedetomidine—Anxiety—Estradiol—osteoporosis	0.000391	0.000911	CcSEcCtD
Dexmedetomidine—Abdominal pain—Zoledronate—osteoporosis	0.000386	0.000899	CcSEcCtD
Dexmedetomidine—Body temperature increased—Zoledronate—osteoporosis	0.000386	0.000899	CcSEcCtD
Dexmedetomidine—Diarrhoea—Risedronate—osteoporosis	0.000385	0.000896	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000385	0.000895	CcSEcCtD
Dexmedetomidine—Dry mouth—Estradiol—osteoporosis	0.000384	0.000894	CcSEcCtD
Dexmedetomidine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000381	0.000888	CcSEcCtD
Dexmedetomidine—Confusional state—Estradiol—osteoporosis	0.000379	0.000884	CcSEcCtD
Dexmedetomidine—Infection—Estradiol—osteoporosis	0.000374	0.000871	CcSEcCtD
Dexmedetomidine—Dizziness—Risedronate—osteoporosis	0.000372	0.000866	CcSEcCtD
Dexmedetomidine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000372	0.000866	CcSEcCtD
Dexmedetomidine—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000372	0.000866	CcSEcCtD
Dexmedetomidine—Tachycardia—Estradiol—osteoporosis	0.000367	0.000855	CcSEcCtD
Dexmedetomidine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000367	0.000854	CcSEcCtD
Dexmedetomidine—Diarrhoea—Pamidronate—osteoporosis	0.000366	0.000852	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Estradiol—osteoporosis	0.000364	0.000847	CcSEcCtD
Dexmedetomidine—Rash—Ethinyl Estradiol—osteoporosis	0.000364	0.000847	CcSEcCtD
Dexmedetomidine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000363	0.000846	CcSEcCtD
Dexmedetomidine—Headache—Ethinyl Estradiol—osteoporosis	0.000361	0.000842	CcSEcCtD
Dexmedetomidine—Vomiting—Risedronate—osteoporosis	0.000358	0.000833	CcSEcCtD
Dexmedetomidine—Rash—Risedronate—osteoporosis	0.000355	0.000826	CcSEcCtD
Dexmedetomidine—Dermatitis—Risedronate—osteoporosis	0.000354	0.000825	CcSEcCtD
Dexmedetomidine—Dizziness—Pamidronate—osteoporosis	0.000354	0.000823	CcSEcCtD
Dexmedetomidine—Headache—Risedronate—osteoporosis	0.000352	0.000821	CcSEcCtD
Dexmedetomidine—Nausea—Ethinyl Estradiol—osteoporosis	0.000343	0.000798	CcSEcCtD
Dexmedetomidine—Vomiting—Pamidronate—osteoporosis	0.00034	0.000792	CcSEcCtD
Dexmedetomidine—Rash—Pamidronate—osteoporosis	0.000337	0.000785	CcSEcCtD
Dexmedetomidine—Dermatitis—Pamidronate—osteoporosis	0.000337	0.000784	CcSEcCtD
Dexmedetomidine—Dyspnoea—Estradiol—osteoporosis	0.000336	0.000781	CcSEcCtD
Dexmedetomidine—Headache—Pamidronate—osteoporosis	0.000335	0.00078	CcSEcCtD
Dexmedetomidine—Somnolence—Estradiol—osteoporosis	0.000335	0.000779	CcSEcCtD
Dexmedetomidine—Diarrhoea—Zoledronate—osteoporosis	0.000334	0.000778	CcSEcCtD
Dexmedetomidine—Nausea—Risedronate—osteoporosis	0.000334	0.000778	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000325	0.000757	CcSEcCtD
Dexmedetomidine—Dizziness—Zoledronate—osteoporosis	0.000323	0.000752	CcSEcCtD
Dexmedetomidine—Pain—Estradiol—osteoporosis	0.000322	0.000749	CcSEcCtD
Dexmedetomidine—Constipation—Estradiol—osteoporosis	0.000322	0.000749	CcSEcCtD
Dexmedetomidine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000322	0.000749	CcSEcCtD
Dexmedetomidine—Nausea—Pamidronate—osteoporosis	0.000318	0.00074	CcSEcCtD
Dexmedetomidine—Dizziness—Conjugated Estrogens—osteoporosis	0.000311	0.000724	CcSEcCtD
Dexmedetomidine—Vomiting—Zoledronate—osteoporosis	0.00031	0.000723	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Estradiol—osteoporosis	0.00031	0.000722	CcSEcCtD
Dexmedetomidine—Rash—Zoledronate—osteoporosis	0.000308	0.000717	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Estradiol—osteoporosis	0.000308	0.000717	CcSEcCtD
Dexmedetomidine—Dermatitis—Zoledronate—osteoporosis	0.000308	0.000716	CcSEcCtD
Dexmedetomidine—Headache—Zoledronate—osteoporosis	0.000306	0.000712	CcSEcCtD
Dexmedetomidine—Vomiting—Conjugated Estrogens—osteoporosis	0.000299	0.000696	CcSEcCtD
Dexmedetomidine—Abdominal pain—Estradiol—osteoporosis	0.000298	0.000693	CcSEcCtD
Dexmedetomidine—Body temperature increased—Estradiol—osteoporosis	0.000298	0.000693	CcSEcCtD
Dexmedetomidine—Rash—Conjugated Estrogens—osteoporosis	0.000296	0.00069	CcSEcCtD
Dexmedetomidine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000296	0.00069	CcSEcCtD
Dexmedetomidine—Headache—Conjugated Estrogens—osteoporosis	0.000295	0.000686	CcSEcCtD
Dexmedetomidine—Nausea—Zoledronate—osteoporosis	0.00029	0.000676	CcSEcCtD
Dexmedetomidine—Nausea—Conjugated Estrogens—osteoporosis	0.000279	0.00065	CcSEcCtD
Dexmedetomidine—Diarrhoea—Estradiol—osteoporosis	0.000257	0.0006	CcSEcCtD
Dexmedetomidine—Dizziness—Estradiol—osteoporosis	0.000249	0.00058	CcSEcCtD
Dexmedetomidine—Vomiting—Estradiol—osteoporosis	0.000239	0.000557	CcSEcCtD
Dexmedetomidine—Rash—Estradiol—osteoporosis	0.000237	0.000553	CcSEcCtD
Dexmedetomidine—Dermatitis—Estradiol—osteoporosis	0.000237	0.000552	CcSEcCtD
Dexmedetomidine—Headache—Estradiol—osteoporosis	0.000236	0.000549	CcSEcCtD
Dexmedetomidine—Nausea—Estradiol—osteoporosis	0.000224	0.000521	CcSEcCtD
Dexmedetomidine—ADRA2B—Signaling Pathways—CNR2—osteoporosis	4.87e-05	0.000501	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—ADCY5—osteoporosis	4.86e-05	0.000501	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—ADCY5—osteoporosis	4.83e-05	0.000498	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—P4HB—osteoporosis	4.8e-05	0.000494	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NFATC1—osteoporosis	4.79e-05	0.000493	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	4.77e-05	0.000492	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR ligand binding—POMC—osteoporosis	4.77e-05	0.000491	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—DKK1—osteoporosis	4.75e-05	0.000489	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CYP27A1—osteoporosis	4.74e-05	0.000489	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—P4HB—osteoporosis	4.72e-05	0.000486	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CALCA—osteoporosis	4.68e-05	0.000482	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PTH—osteoporosis	4.67e-05	0.000481	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—P4HB—osteoporosis	4.66e-05	0.00048	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ACP5—osteoporosis	4.62e-05	0.000475	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PTH—osteoporosis	4.59e-05	0.000473	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RAP1A—osteoporosis	4.59e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PTHLH—osteoporosis	4.59e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—BMP2—osteoporosis	4.59e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—OXCT1—osteoporosis	4.58e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CA2—osteoporosis	4.58e-05	0.000472	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—WNT1—osteoporosis	4.58e-05	0.000471	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GAPDH—osteoporosis	4.57e-05	0.000471	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PNP—osteoporosis	4.57e-05	0.00047	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ATIC—osteoporosis	4.57e-05	0.00047	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.56e-05	0.000469	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—TPI1—osteoporosis	4.55e-05	0.000469	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CNR2—osteoporosis	4.55e-05	0.000468	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TLN1—osteoporosis	4.52e-05	0.000465	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—ADCY5—osteoporosis	4.51e-05	0.000465	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RAP1A—osteoporosis	4.51e-05	0.000465	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—FGB—osteoporosis	4.49e-05	0.000462	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CNR2—osteoporosis	4.48e-05	0.000461	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NFATC1—osteoporosis	4.47e-05	0.000461	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MGLL—osteoporosis	4.47e-05	0.00046	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.46e-05	0.000459	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—RAP1A—osteoporosis	4.45e-05	0.000459	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—FGA—osteoporosis	4.45e-05	0.000459	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—ADCY5—osteoporosis	4.44e-05	0.000458	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—DKK1—osteoporosis	4.44e-05	0.000457	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ENO1—osteoporosis	4.43e-05	0.000457	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NFATC1—osteoporosis	4.4e-05	0.000453	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—ADCY5—osteoporosis	4.39e-05	0.000452	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PSMA2—osteoporosis	4.37e-05	0.00045	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PSMA5—osteoporosis	4.37e-05	0.00045	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—DKK1—osteoporosis	4.37e-05	0.00045	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PSMA2—osteoporosis	4.33e-05	0.000446	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PSMA5—osteoporosis	4.33e-05	0.000446	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—TPI1—osteoporosis	4.29e-05	0.000442	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—P4HB—osteoporosis	4.28e-05	0.000441	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—WNT1—osteoporosis	4.28e-05	0.00044	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—WNT1—osteoporosis	4.21e-05	0.000433	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GAPDH—osteoporosis	4.2e-05	0.000433	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FGA—osteoporosis	4.16e-05	0.000428	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PTHLH—osteoporosis	4.14e-05	0.000426	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—BMP2—osteoporosis	4.14e-05	0.000426	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—IGF1—osteoporosis	4.1e-05	0.000423	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—ADCY5—osteoporosis	4.1e-05	0.000422	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FGA—osteoporosis	4.09e-05	0.000422	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—RAP1A—osteoporosis	4.09e-05	0.000421	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—FGB—osteoporosis	4.05e-05	0.000417	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CALCA—osteoporosis	4.04e-05	0.000416	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—P4HB—osteoporosis	4.03e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—ADCY5—osteoporosis	4.03e-05	0.000415	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GAPDH—osteoporosis	3.96e-05	0.000408	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—POMC—osteoporosis	3.94e-05	0.000405	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PSMA2—osteoporosis	3.91e-05	0.000403	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PSMA5—osteoporosis	3.91e-05	0.000403	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—P4HB—osteoporosis	3.9e-05	0.000401	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—OXCT1—osteoporosis	3.88e-05	0.0004	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CA2—osteoporosis	3.88e-05	0.0004	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PTHLH—osteoporosis	3.87e-05	0.000398	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—BMP2—osteoporosis	3.87e-05	0.000398	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—RAP1A—osteoporosis	3.86e-05	0.000397	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—BMP2—osteoporosis	3.81e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PTHLH—osteoporosis	3.81e-05	0.000392	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—IDH2—osteoporosis	3.8e-05	0.000391	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PTH—osteoporosis	3.79e-05	0.00039	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MGLL—osteoporosis	3.78e-05	0.00039	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FGB—osteoporosis	3.78e-05	0.00039	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RAP1A—osteoporosis	3.73e-05	0.000384	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FGB—osteoporosis	3.72e-05	0.000384	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CNR2—osteoporosis	3.69e-05	0.00038	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—ADCY5—osteoporosis	3.67e-05	0.000378	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—KL—osteoporosis	3.67e-05	0.000377	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PSMA5—osteoporosis	3.65e-05	0.000376	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PSMA2—osteoporosis	3.65e-05	0.000376	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CALCA—osteoporosis	3.64e-05	0.000375	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NFATC1—osteoporosis	3.63e-05	0.000374	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DKK1—osteoporosis	3.61e-05	0.000371	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ENO1—osteoporosis	3.6e-05	0.000371	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	3.6e-05	0.00037	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	3.6e-05	0.00037	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—POMC—osteoporosis	3.58e-05	0.000368	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP27A1—osteoporosis	3.57e-05	0.000368	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	3.57e-05	0.000367	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	3.55e-05	0.000366	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PSMA2—osteoporosis	3.55e-05	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PSMA5—osteoporosis	3.55e-05	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—CYP19A1—osteoporosis	3.54e-05	0.000365	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	3.49e-05	0.000359	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ACP5—osteoporosis	3.47e-05	0.000358	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	3.47e-05	0.000358	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CALCA—osteoporosis	3.4e-05	0.000351	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FGA—osteoporosis	3.38e-05	0.000348	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.36e-05	0.000346	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CALCA—osteoporosis	3.35e-05	0.000345	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	3.33e-05	0.000343	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	3.32e-05	0.000342	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—KL—osteoporosis	3.31e-05	0.000341	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ENO1—osteoporosis	3.31e-05	0.000341	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	3.27e-05	0.000337	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PSMA2—osteoporosis	3.26e-05	0.000336	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PSMA5—osteoporosis	3.26e-05	0.000336	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—TGFB1—osteoporosis	3.24e-05	0.000334	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TPI1—osteoporosis	3.23e-05	0.000333	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	3.23e-05	0.000332	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—IDH2—osteoporosis	3.22e-05	0.000331	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	3.15e-05	0.000324	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	3.14e-05	0.000323	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	3.14e-05	0.000323	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ENO1—osteoporosis	3.12e-05	0.000321	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—KL—osteoporosis	3.09e-05	0.000318	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FGB—osteoporosis	3.07e-05	0.000317	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PSMA5—osteoporosis	3.07e-05	0.000316	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PSMA2—osteoporosis	3.07e-05	0.000316	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—KL—osteoporosis	3.04e-05	0.000313	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—P4HB—osteoporosis	3.04e-05	0.000313	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—TGFB1—osteoporosis	3.03e-05	0.000312	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP27A1—osteoporosis	3.03e-05	0.000312	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	3.02e-05	0.000311	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GAPDH—osteoporosis	2.98e-05	0.000307	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	2.97e-05	0.000306	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	2.97e-05	0.000306	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	2.97e-05	0.000306	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ACP5—osteoporosis	2.94e-05	0.000303	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	2.94e-05	0.000303	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.91e-05	0.000299	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—RAP1A—osteoporosis	2.9e-05	0.000299	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ADCY5—osteoporosis	2.9e-05	0.000298	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	2.89e-05	0.000298	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—GPX1—osteoporosis	2.89e-05	0.000297	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CYP19A1—osteoporosis	2.88e-05	0.000296	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	2.87e-05	0.000296	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SPP1—osteoporosis	2.78e-05	0.000286	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	2.77e-05	0.000285	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TPI1—osteoporosis	2.74e-05	0.000282	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	2.7e-05	0.000278	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—MTHFR—osteoporosis	2.66e-05	0.000274	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CYP19A1—osteoporosis	2.64e-05	0.000272	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	2.59e-05	0.000267	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—P4HB—osteoporosis	2.57e-05	0.000265	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GAPDH—osteoporosis	2.52e-05	0.00026	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	2.51e-05	0.000259	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KL—osteoporosis	2.51e-05	0.000259	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	2.51e-05	0.000258	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CYP19A1—osteoporosis	2.49e-05	0.000257	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—TGFB1—osteoporosis	2.46e-05	0.000253	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—RAP1A—osteoporosis	2.46e-05	0.000253	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—LEP—osteoporosis	2.46e-05	0.000253	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	2.45e-05	0.000252	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	2.42e-05	0.000249	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	2.39e-05	0.000246	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	2.38e-05	0.000245	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ADCY5—osteoporosis	2.35e-05	0.000242	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	2.35e-05	0.000242	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ENO1—osteoporosis	2.35e-05	0.000242	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GPX1—osteoporosis	2.34e-05	0.000241	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	2.34e-05	0.000241	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PSMA2—osteoporosis	2.31e-05	0.000238	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PSMA5—osteoporosis	2.31e-05	0.000238	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	2.31e-05	0.000237	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	2.27e-05	0.000234	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—LEP—osteoporosis	2.22e-05	0.000229	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	2.19e-05	0.000226	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—MTHFR—osteoporosis	2.16e-05	0.000223	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ADCY5—osteoporosis	2.16e-05	0.000222	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GPX1—osteoporosis	2.15e-05	0.000222	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.14e-05	0.000221	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—POMC—osteoporosis	2.13e-05	0.000219	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	2.12e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	2.12e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—POMC—osteoporosis	2.11e-05	0.000218	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	2.09e-05	0.000215	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—LEP—osteoporosis	2.07e-05	0.000214	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	2.06e-05	0.000212	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—LEP—osteoporosis	2.04e-05	0.00021	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ADCY5—osteoporosis	2.04e-05	0.00021	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	2.03e-05	0.000209	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GPX1—osteoporosis	2.03e-05	0.000209	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ENO1—osteoporosis	1.99e-05	0.000205	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—MTHFR—osteoporosis	1.99e-05	0.000205	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	1.98e-05	0.000204	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	1.98e-05	0.000204	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	1.97e-05	0.000203	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PSMA2—osteoporosis	1.96e-05	0.000202	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PSMA5—osteoporosis	1.96e-05	0.000202	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	1.95e-05	0.000201	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—POMC—osteoporosis	1.91e-05	0.000196	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	1.9e-05	0.000196	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.88e-05	0.000193	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—MTHFR—osteoporosis	1.87e-05	0.000193	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	1.86e-05	0.000192	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	1.85e-05	0.00019	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	1.83e-05	0.000189	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	1.82e-05	0.000187	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—osteoporosis	1.78e-05	0.000183	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—osteoporosis	1.75e-05	0.000181	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	1.74e-05	0.000179	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—osteoporosis	1.73e-05	0.000178	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	1.72e-05	0.000177	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	1.71e-05	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	1.71e-05	0.000176	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	1.69e-05	0.000174	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—LEP—osteoporosis	1.68e-05	0.000173	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	1.61e-05	0.000166	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP19A1—osteoporosis	1.59e-05	0.000164	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—osteoporosis	1.59e-05	0.000164	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	1.55e-05	0.00016	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ADCY5—osteoporosis	1.53e-05	0.000158	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—osteoporosis	1.53e-05	0.000157	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	1.5e-05	0.000155	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—osteoporosis	1.5e-05	0.000154	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—osteoporosis	1.45e-05	0.000149	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	1.41e-05	0.000145	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—MTHFR—osteoporosis	1.41e-05	0.000145	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	1.4e-05	0.000144	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	1.39e-05	0.000143	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	1.31e-05	0.000135	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADCY5—osteoporosis	1.3e-05	0.000134	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—osteoporosis	1.29e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	1.29e-05	0.000133	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MYC—osteoporosis	1.22e-05	0.000126	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	1.22e-05	0.000125	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—MTHFR—osteoporosis	1.19e-05	0.000123	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—osteoporosis	1.13e-05	0.000116	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MYC—osteoporosis	1.1e-05	0.000114	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	1.1e-05	0.000113	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	1.06e-05	0.00011	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MYC—osteoporosis	1.03e-05	0.000106	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	1.03e-05	0.000106	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MYC—osteoporosis	1.01e-05	0.000104	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	1.01e-05	0.000104	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—osteoporosis	9.55e-06	9.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6—osteoporosis	9.18e-06	9.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MYC—osteoporosis	8.36e-06	8.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	8.34e-06	8.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6—osteoporosis	8.29e-06	8.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6—osteoporosis	7.74e-06	7.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6—osteoporosis	7.62e-06	7.84e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6—osteoporosis	6.29e-06	6.47e-05	CbGpPWpGaD
